Eli Lilly (LLY) Stock Price, Quote, News & History | Benzinga

SPY766.07 QQQ740.26+0.32%BTC/USD83,166.66−0.55%DIA514.17+0.25%GLD383.54+0.17%TLT78.42+0.24%

Eli Lilly and Co (LLY) Stock Price, Quote, News & History

LLYNYSE

Trade with Public

Trade with Public

$1186.07

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Dividends Compare Options Stock Report

Key Statistics

Open

-

Close

-

Volume / Avg.

0 / 2.55M

Day Range

- - -

52 Wk Range

716.08 - 1.29K

Market Cap

$1.06T

P/E Ratio

39.77

Dividend Yield

0.58%

Exchange

NYSE

RSI

57

Short Interest

0.84%

Days to Cover

3.41

Recent Eli Lilly and Company News

Donald Trump, Cathie Wood Bet on the Same 32 Stocks – Some Might Surprise You

A look at the stocks that are owned by Cathie Wood's Ark Invest and Donald Trump.

Chris Katje

Weight Watchers Expands GLP-1 Era Strategy With Google Health

Weight Watchers partners with Google Health to integrate Fitbit data and AI insights into select employer programs. WW stock surges 12%.

Neeraj Jain

Tirzepatide or Wegovy? Novo Nordisk Says Higher Semaglutide Dose Shows Cardiovascular Edge Over Eli Lilly's Tirzepatide

Novo Nordisk reports lower cardiovascular risk for semaglutide over tirzepatide and secures a $2.6 billion licensing deal.

Vandana Singh

Wegovy or Zepbound? Eli Lilly Shows Zepbound Outperforms Wegovy in New Weight Loss Data

Eli Lilly says Zepbound and Foundayo provide superior weight loss and blood sugar control over Novo Nordisk's semaglutide treatments.

Vandana Singh

Eli Lilly Launches Global Push to Expand Weight-Loss and Diabetes Drug Access in Lower Income Countries

Eli Lilly launches a global commitment to close the diabetes and obesity treatment gap in low-income countries by 2040.

Tanya Rawat

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

28.08B

Investing Cash Flow (TTM)

-25.10B

Financing Cash Flow (TTM)

2.61B

Free Cash Flow (TTM)

13.56B

Capital Expenditure (TTM)

-14.52B

Net Change in Cash (TTM)

5.59B

Analyst Trends and Forecast

2

Jun

10

Jul

3

Aug

3

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$1.10T

PE Ratio (TTM)

39.77

PE Ratio (FWD)

25.13

PEG Ratio (TTM)

1.17

PS Ratio (TTM)

13.33

PB Ratio (TTM)

31.17

Earnings Yield % (TTM)

2.51%

Earnings Yield % (FWD)

3.98%

EV / EBITDA (TTM)

26.42

Price / EBITDA (TTM)

25.47

Price / Free Cash Flow (TTM)

78.33

Book Value / Share

$38.01

Company Debt

Total Debt

$54.91B

LT Debt

$47.86B

LT Debt Issuance (TTM)

$15.65B

LT Debt Repayment (TTM)

-$1.62B

Total Cash

$8.95B

Debt to Equity

1.62

Issuance of Debt (TTM)

$14.02B

Repayment of Debt (TTM)

-$1.62B

Key Statistics

Open

-

Close

-

Volume / Avg.

0 / 2.55M

Day Range

- - -

52 Wk Range

716.08 - 1.29K

Market Cap

$1.06T

P/E Ratio

39.77

Dividend Yield

0.58%

Exchange

NYSE

RSI

57

Short Interest

0.84%

Days to Cover

3.41

About

Sector

Health Care

Industry

Pharmaceuticals

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometaboli...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

FAQ

Q

How do I buy Eli Lilly (LLY) stock?

A

You can purchase shares of Eli Lilly (NYSE:LLY) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Eli Lilly (LLY) competitors?

A

Other companies in Eli Lilly’s space includes: Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS), AstraZeneca PLC (NYSE:AZN) and Novo Nordisk AS (NYSE:NVO).

Q

What is the forecast, or price target, for Eli Lilly (LLY) stock?

A

Eli Lilly has a consensus price target of $1244.57.

Q

What is the current price for Eli Lilly (LLY)?

A

The stock price for Eli Lilly (NYSE: LLY) is $1186.0729 last updated September 29, 2026 at 7:08 PM EDT.

Q

Does Eli Lilly (LLY) pay a dividend?

A

There are no upcoming dividends for Eli Lilly.

Q

When is Eli Lilly (NYSE:LLY) reporting earnings?

A

Eli Lilly does not have any upcoming earnings scheduled.

Q

Is Eli Lilly (LLY) going to split?

A

There is no upcoming split for Eli Lilly.

Q

What sector and industry does Eli Lilly (LLY) operate in?

A

Eli Lilly is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.